Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Receivables (2021 - 2025)

Historic Change in Receivables for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to $545000.0.

  • MDxHealth's Change in Receivables rose 17394.84% to $545000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$228000.0, marking a year-over-year increase of 9241.01%. This contributed to the annual value of -$3.2 million for FY2024, which is 9168.15% down from last year.
  • Latest data reveals that MDxHealth reported Change in Receivables of $545000.0 as of Q3 2025, which was up 17394.84% from $24000.0 recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Change in Receivables peaked at $545000.0 during Q3 2025, and registered a low of -$1.1 million during Q1 2025.
  • Moreover, its 4-year median value for Change in Receivables was -$479000.0 (2022), whereas its average is -$381888.9.
  • The largest annual percentage gain for MDxHealth's Change in Receivables in the last 5 years was 17394.84% (2025), contrasted with its biggest fall of 17394.84% (2025).
  • Over the past 4 years, MDxHealth's Change in Receivables (Quarter) stood at -$704000.0 in 2021, then crashed by 53.98% to -$1.1 million in 2022, then surged by 128.6% to $310000.0 in 2024, then surged by 75.81% to $545000.0 in 2025.
  • Its last three reported values are $545000.0 in Q3 2025, $24000.0 for Q2 2025, and -$1.1 million during Q1 2025.